Precise null deletion mutations of the mycothiol synthesis genes reveal their role in isoniazid and ethionamide resistance in Mycobacterium smegmatis

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3133-3139

  Xu, Xia ^a   Vilchèze, Catherine ^a   Av Gay, Yossef ^b   Gómez Velasco, Anaximandro ^b   Jacobs Jr , William R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ETHIONAMIDE; GLUTATHIONE DERIVATIVE; ISONIAZID; MYCOTHIOL; MYCOTHIOL A; MYCOTHIOL B; MYCOTHIOL C; MYCOTHIOL D; MYCOTHIOL S CONJUGATE AMIDASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; GENE DELETION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CYSTEINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHIONAMIDE; GLYCOPEPTIDES; INOSITOL; ISONIAZID; MYCOBACTERIUM SMEGMATIS; SEQUENCE DELETION;

EID: 79959226734     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00020-11     Document Type: Article

References (41)

1. Banerjee, A., et al. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230. (Pubitemid 24067929)
2. Bardarov, S., et al. 2002. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148:3007-3017. (Pubitemid 35243700)
3. Bardou, F., C. Raynaud, C. Ramos, M. A. Laneelle, and G. Laneelle. 1998. Mechanism of isoniazid uptake in Mycobacterium tuberculosis. Microbiology 144(Pt 9):2539-2544. (Pubitemid 28457163)
4. Baulard, A. R., et al. 2000. Activation of the pro-drug ethionamide is regulated in mycobacteria. J. Biol. Chem. 275:28326-28331.
5. Bernstein, J., W. A. Lott, B. A. Steinberg, and H. L. Yale. 1952. Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds. Am. Rev. Tuberc. 65:357-364.
6. Buchmeier, N. A., G. L. Newton, and R. C. Fahey. 2006. A mycothiol synthase mutant of Mycobacterium tuberculosis has an altered thiol-disulfide content and limited tolerance to stress. J. Bacteriol. 188:6245-6252.
7. Buchmeier, N. A., G. L. Newton, T. Koledin, and R. C. Fahey. 2003. Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics. Mol. Microbiol. 47:1723-1732.
8. Bzymek, K. P., G. L. Newton, P. Ta, and R. C. Fahey. 2007. Mycothiol import by Mycobacterium smegmatis and function as a resource for metabolic precursors and energy production. J. Bacteriol. 189:6796-6805.
9. Fox, H. H. 1952. The chemical approach to the control of tuberculosis. Science 116:129-134.
10. Hazbon, M. H., et al. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50:2640-2649.
11. Koledin, T., G. L. Newton, and R. C. Fahey. 2002. Identification of the mycothiol synthase gene (mshD) encoding the acetyltransferase producing mycothiol in actinomycetes. Arch. Microbiol. 178:331-337.
12. Morlock, G. P., B. Metchock, D. Sikes, J. T. Crawford, and R. C. Cooksey. 2003. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 47:3799-3805.
13. Mukherjee, J. S., et al. 2004. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 363:474-481. (Pubitemid 38210067)
14. Newton, G. L., et al. 1996. Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J. Bacteriol. 178:1990-1995. (Pubitemid 26110543)
15. Newton, G. L., Y. Av-Gay, and R. C. Fahey. 2000. N-Acetyl-1-D-myo- inosityl- 2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) is a key enzyme in mycothiol biosynthesis. J. Bacteriol. 182:6958-6963.
16. Newton, G. L., Y. Av-Gay, and R. C. Fahey. 2000. A novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidase. Biochemistry 39:10739-10746.
17. Newton, G. L., N. Buchmeier, and R. C. Fahey. 2008. Biosynthesis and functions of mycothiol, the unique protective thiol of actinobacteria. Microbiol. Mol. Biol. Rev. 72:471-494.
18. Newton, G. L., et al. 2003. The glycosyltransferase gene encoding the enzyme catalyzing the first step of mycothiol biosynthesis (mshA). J. Bacteriol. 185:3476-3479.
19. Newton, G. L., P. Ta, and R. C. Fahey. 2005. A mycothiol synthase mutant of Mycobacterium smegmatis produces novel thiols and has an altered thiol redox status. J. Bacteriol. 187:7309-7316.
20. Quemard, A., et al. 1995. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34:8235-8241.
21. Rawat, M., S. Kovacevic, H. Billman-Jacobe, and Y. Av-Gay. 2003. Inactivation of mshB, a key gene in the mycothiol biosynthesis pathway in Mycobacterium smegmatis. Microbiology 149:1341-1349. (Pubitemid 36626181)
22. Rawat, M., et al. 2002. Mycothiol-deficient Mycobacterium smegmatis mutants are hypersensitive to alkylating agents, free radicals, and antibiotics. Antimicrob. Agents Chemother. 46:3348-3355.
23. Rawat, M., et al. 2004. Targeted mutagenesis of the Mycobacterium smegmatis mca gene, encoding a mycothiol-dependent detoxification protein. J. Bacteriol. 186:6050-6058. (Pubitemid 39186993)
24. Rawat, R., A. Whitty, and P. J. Tonge. 2003. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 100:13881-13886.
25. Rozwarski, D. A., G. A. Grant, D. H. Barton, W. R. Jacobs, Jr., and J. C. Sacchettini. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279:98-102.
26. Sambandamurthy, V. K., et al. 2002. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat. Med. 8:1171-1174.
27. Sareen, D., M. Steffek, G. L. Newton, and R. C. Fahey. 2002. ATP-dependent L-cysteine:1D-myo-inosityl 2-amino-2-deoxy-alpha-D-glucopyranoside ligase, mycothiol biosynthesis enzyme MshC, is related to class I cysteinyl-tRNA synthetases. Biochemistry 41:6885-6890.
28. Shoeb, H. A., B. U. Bowman, Jr., A. C. Ottolenghi, and A. J. Merola. 1985. Peroxidase-mediated oxidation of isoniazid. Antimicrob. Agents Chemother. 27:399-403.
29. Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs, Jr. 1990. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911-1919.
30. Spies, H. S., and D. J. Steenkamp. 1994. Thiols of intracellular pathogens. Identification of ovothiol A in Leishmania donovani and structural analysis of a novel thiol from Mycobacterium bovis. Eur. J. Biochem. 224:203-213.
31. Stover, C. K., et al. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460. (Pubitemid 21896614)
32. Takayama, K., L. Wang, and H. L. David. 1972. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2:29-35.
33. Ung, K. S., and Y. Av-Gay. 2006. Mycothiol-dependent mycobacterial response to oxidative stress. FEBS Lett. 580:2712-2716. (Pubitemid 44294505)
34. Vilcheze, C., et al. 2008. Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Mol. Microbiol. 69:1316-1329.
35. Vilcheze, C., et al. 2000. Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J. Bacteriol. 182:4059-4067. (Pubitemid 30436569)
36. Vilcheze, C., et al. 2005. Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob. Agents Chemother. 49:708-720.
37. Wang, F., et al. 2007. Mechanism of thioamide drug action against tuberculosis and leprosy. J. Exp. Med. 204:73-78.
38. Wilming, M., and K. Johnsson. 1999. Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid. Angew. Chem. Int. ed. Engl. 38:2588-2590.
39. World Health Organization. 2009. Epidemiology. In Global tuberculosis control - epidemiology, strategy, financing. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/publications/global-report/2009/pdf/chapter1. pdf.
40. Zhang, Y., T. Garbe, and D. Young. 1993. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 8:521-524.
41. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.